AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Opglim MV 1mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Opsiscare Lifesciences Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Opglim MV 1mg/500mg/0.2mg Tablet

Opglim MV 1mg/500mg/0.2mg tablets are classified as antidiabetic agents, a combination medication for managing type 2 diabetes in adults. This medication helps regulate blood glucose levels. Administer Opglim MV with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continue using this medication as directed, even if feeling well or experiencing controlled blood sugar, as discontinuation without medical consultation can elevate blood glucose, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as advised by your doctor. Lifestyle choices are crucial for diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Maintain regular mealtimes and carry a rapid-acting glucose source (e.g., sugary snacks, juice). Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended.

Uses of Opglim MV 1mg/500mg/0.2mg Tablet

Managing type 2 diabetes

Major Benefits of Opglim MV 1mg/500mg/0.2mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Opglim MV 1mg/500mg/0.2mg Tablets should be administered on an empty stomach.

Common Side effects of Opglim MV 1mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Opglim MV 1mg/500mg/0.2mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Opglim MV 1mg/500mg/0.2mg tablets should be administered on an empty stomach.

How Opglim MV 1mg/500mg/0.2mg Tablet works:

Each Opglim MV tablet (1mg/500mg/0.2mg) combines three distinct antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Opglim MV 1mg/500mg/0.2mg Tablet with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Opglim MV 1mg/500mg/0.2mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Opglim MV 1mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyUNSAFE

The use of Opglim MV 1mg/500mg/0.2mg tablets is likely unsafe for individuals with kidney impairment and should be prevented. Medical advice is essential. Furthermore, its use is contraindicated in patients exhibiting severe kidney dysfunction.

LiverLiverCAUTION

Patients with liver disease should use Opglim MV 1mg/500mg/0.2mg tablets cautiously, as dose modification may be necessary. A physician's consultation is advised. For individuals with mild to moderate liver impairment, Opglim MV 1mg/500mg/0.2mg tablets are typically initiated at a low dosage; however, their use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Opglim MV 1mg/500mg/0.2mg Tablet :

Should you forget to take your Opglim MV 1mg/500mg/0.2mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Opglim MV 1mg/500mg/0.2mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Opglim MV 1mg/500mg/0.2mg Tablet

Opglim MV 1mg/500mg/0.2mg tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release, metformin reduces liver glucose production and enhances insulin sensitivity, while voglibose, an alpha-glucosidase inhibitor, lowers post-meal glucose levels. This medication is not suitable for type 1 diabetes.
Opglim MV 1mg/500mg/0.2mg Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste perception, flatulence, stomach pain, headache, skin rash, and respiratory infections.
Opglim MV 1mg/500mg/0.2mg Tablet is contraindicated in patients allergic to its components or excipients, those with moderate to severe kidney disease, and those with inflammatory bowel disease, colonic ulcers, or underlying metabolic acidosis (including diabetic ketoacidosis).
Combining Opglim MV 1mg/500mg/0.2mg Tablet with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Opglim MV 1mg/500mg/0.2mg Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and ensure it remains inaccessible to children, pets, and others.
Opglim MV 1mg/500mg/0.2mg...
123
MRP 150
18% off